Dan Lemaitre sold $1.2M of GMED
director at GLOBUS MEDICAL INC. 14,375 shares at an average of $85.00, traded Nov 21, 2024, filed Nov 25, 2024.
Score components
- +15RoleDirector
- +25Trade size$1.2M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-130597, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2024 | MOption exercise Class A Common Stock | +13,278 | $65.05 | $864k | 13,278 | Nov 25, 2024 |
| Nov 21, 2024 | SOpen-market sale Class A Common Stock | -13,278 | $85.00 | $1.1M | 0 | Nov 25, 2024 |
| Nov 22, 2024 | MOption exercise Class A Common Stock | +1,097 | $65.05 | $71k | 1,097 | Nov 25, 2024 |
| Nov 22, 2024 | SOpen-market sale Class A Common Stock | -1,097 | $85.02 | $93k | 0 | Nov 25, 2024 |
| Nov 21, 2024 | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative | -13,278 | $0.00 | $0 | 1,722 | Nov 25, 2024 |
| Nov 22, 2024 | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative | -1,097 | $0.00 | $0 | 625 | Nov 25, 2024 |
Related signals
Other insiders at GLOBUS MEDICAL INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 45Moderate | sell | GMED GLOBUS MEDICAL INC | James R Tobin director | $2.2M | 30,000 | |
| 19Weak | sell10b5-1 | GMED GLOBUS MEDICAL INC | Ann D Rhoads director | $590k | 7,500 | |
| 32Weak | sell10b5-1 | GMED GLOBUS MEDICAL INC | Keith W Pfeil COO, CFO | $1.3M | 14,167 | |
| 27Weak | sell 410b5-1 | GMED GLOBUS MEDICAL INC | Kelly Huller SVP, GC, Corporate Secretary | $218k | 2,500 | |
| 35Weak | sell 410b5-1 | GMED GLOBUS MEDICAL INC | David D Davidar director | $3.4M | 40,000 | |
| 50Moderate | sell 410b5-1 | GMED GLOBUS MEDICAL INC | Daniel T Scavilla President, CEO | $11M | 130,000 | |
| 43Moderate | sell 210b5-1 | GMED GLOBUS MEDICAL INC | Daniel T Scavilla President, CEO | $4.8M | 60,000 | |
| 24Weak | sell 210b5-1 | GMED GLOBUS MEDICAL INC | Kelly Huller SVP, GC, Corporate Secretary | $405k | 5,000 | |
| 28Weak | sell 210b5-1 | GMED GLOBUS MEDICAL INC | David D Davidar director | $3.8M | 50,000 | |
| 7Weak | sell 210b5-1 | GMED GLOBUS MEDICAL INC | Kelly Huller SVP, GC, Corporate Secretary | $563k | 7,500 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.